Conversely, studies have demonstrated that soy isoflavones contribute to the suppression of breast cancer cell proliferation via ER-independent mechanisms, specifically by inhibiting DNA topoisomerases and tyrosine kinases, as suggested by certain investigations [159,160,161]. Here, ESR1 is linked to breast carcinoma.